Session Chair Profile

Ph.D., Professor, UCSF

Dr. Wu's research involves pharmacogenomics, cardiac biomarkers and clinical toxicology. With the onset of the COVID-19 pandemic, he has switch his focus towards molecular testing for the virus, antigen and antibodies after an infection and after a vaccine. Throughout his career, he has been a leader in promoting the value of clinical laboratory testing to the medical world, but especially the lay public. During the early months of the pandemic, the absence lab testing availability was directly linked to the spread of the virus.

Panel Discussion on COVID-19 Testing
COVID-19 Testing: Who, When, What? The Challenges of Testing during the Pandemic. In this panel, we will discuss how testing has evolved from the early months of the pandemic to the current unmet medical needs.